Startups

TTTTT

Our startups

Be inspired. Search our startups.

Filter
Silver Winners
2017 Boston Silver Winner

UrSure Inc. aims to prevent HIV by driving adherence to the drug, PrEP. If taken daily, PrEP is 99% effective at preventing HIV infections in non-infected individuals. Nationwide, PrEP adherence is estimated between 20 and 50%, but UrSure Inc. has driven adherence to over 70% in its HIV prevention clinic in Philadelphia through its urine tests. UrSure’s urine tests are noninvasive and painless, cheaper, more accurate, and have a faster turnaround time than alternative PrEP tests.

Startups
2017 Boston Silver Winner

UrSure Inc. aims to prevent HIV by driving adherence to the drug, PrEP. If taken daily, PrEP is 99% effective at preventing HIV infections in non-infected individuals. Nationwide, PrEP adherence is estimated between 20 and 50%, but UrSure Inc. has driven adherence to over 70% in its HIV prevention clinic in Philadelphia through its urine tests. UrSure’s urine tests are noninvasive and painless, cheaper, more accurate, and have a faster turnaround time than alternative PrEP tests.